Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Phase I Study of Sequential Cord Blood Transplants [Phase 1]
Phase I study of sequential cord blood transplants has completed enrollment for conditions including lymphoma, leukemia, multiple myeloma, a…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection [Phase 2]
Phase 2 clinical trial update evaluating caspofungin-based combination antifungal therapy for proven or probable invasive fungal infection i…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
A Duke University registry study evaluating T-cell depleted allogeneic non-myeloablative stem cell transplantation for hematologic cancers h…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Korean Post-marketing Surveillance for Sprycel®
This is a completed Korean post-marketing surveillance study of Sprycel (dasatinib). It covered patients with chronic myelomonocytic leukemi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: T-Cell Depletion in Unrelated Donor Marrow Transplantation [Phase 3]
Phase 3 trial evaluating T-cell depletion in unrelated donor bone marrow transplantation has completed, studying its impact on graft-versus-…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Cord Blood Stem Cell Transplantation Study (COBLT) [Phase 2]
Phase 2 COBLT cord blood stem cell transplantation trial sponsored by NHLBI has completed, studying transplantation for aplastic anemia, Fan…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients [Phase 4]
A Phase 4 trial comparing subcutaneous versus intravenous administration of granulocyte colony-stimulating factor (G-CSF) for neutropenia in…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) [Phase 2]
A Phase 2 study evaluating donor lymphocyte infusion after allogeneic stem cell transplantation in leukemia and lymphoma was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia [Phase 1]
Phase 1 study of Terameprocol (EM-1421) in leukemia was terminated; no efficacy results were reported in this update.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma [Phase 3]
A Phase 3 trial comparing two combination chemotherapy regimens in adults with previously untreated leukemia or lymphoma has completed, with…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Blood and Marrow Transplant Clinical Research Network [NA]
The Blood and Marrow Transplant Clinical Research Network study has completed, summarizing transplantation approaches across hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating chemotherapy plus donor natural killer cell infusion for patients with relapsed or persistent leukemia or myelody…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy [Phase 2]
This Phase 2 study from Memorial Sloan Kettering Cancer Center evaluated a myeloablative conditioning regimen with total body irradiation fo…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor [Phase 2]
Phase II study evaluating a myeloablative conditioning regimen of busulfan, melphalan, and fludarabine followed by an allogeneic hematopoiet…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) [Phase 3]
Phase 3 trial comparing peripheral blood stem cell transplant to bone marrow transplant in hematologic cancers completed.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT [NA]
This trial assessed whether rituximab (Rituxan) can prevent EBV-associated lymphoproliferative disorder after T-cell-depleted unrelated or H…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Phase 2]
A Phase 2 trial evaluating tretinoin and arsenic trioxide with or without idarubicin for acute promyelocytic leukemia was terminated, and re…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 trial updating chemotherapy plus monoclonal antibody therapy in patients with advanced myeloid cancers; the study is complet…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases [Phase 2]
Phase 2 trial evaluating total body irradiation with fludarabine-based conditioning followed by haploidentical transplantation for hematolog…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation [NA]
This clinical trial update reports completion of a study evaluating Traumeel S for prevention and treatment of mucositis in pediatric stem c…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG [Phase 2]
Phase 2 clinical trial evaluating alloreactive haploidentical natural killer cells with busulfan and fludarabine/ATG conditioning in leukemi…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation after a busulfan/fludarabine/methylprednisolone/antithymocyte globulin conditioning…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia [NA]
Clinical trial results for umbilical cord blood transplantation in pediatric patients with high-risk leukemia and myelodysplasia; the study …
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia [Phase 2]
Phase 2 clinical trial update evaluating T-cell-depleted bone marrow and G-CSF-stimulated peripheral stem cell transplantation from related …